Revista de la Sociedad Argentina de Diabetes (Sep 2022)

Symposium 20: Initial approach to the patient with NAFLD

  • Adrián Narváez

DOI
https://doi.org/10.47196/diab.v56i3Sup.646
Journal volume & issue
Vol. 56, no. 3Sup
pp. 107 – 107

Abstract

Read online

Steatosis (fatty liver) is defined as fatty infiltration of more than 5% of hepatocytes. Its prevalence in the general population is approximately 30%, being higher in special populations such as diabetes and obesity. Also with greater possibility of progressing to more serious forms of the disease. Type 2 diabetes is one of the strongest clinical predictors of progression from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis.

Keywords